Ocular Therapeutix
OCUL
$5.56
Share price
10.76%
Change (1 day)
-10.03%
Change (1 year)
Categories
Ocular Therapeutix (OCUL) - Cash on Hand
Cash on Hand as of December 2023 : $0.19 B
According to Ocular Therapeutix's latest financial reports the company has $0.19 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Ocular Therapeutix - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.19 B | 91.4% |
| 2022-12-31 | $0.10 B | -37.68% |
| 2021-12-31 | $0.16 B | -28.02% |
| 2020-12-31 | $0.22 B | 318.94% |
| 2019-12-31 | $54.43 M | 0.69% |
| 2018-12-31 | $54.06 M | 30.15% |
| 2017-12-31 | $41.53 M | -39.04% |
| 2016-12-31 | $68.14 M | -35.14% |
| 2015-12-31 | $0.10 B | 40.41% |
| 2014-12-31 | $74.82 M | 327.47% |
| 2013-12-31 | $17.5 M | -26.62% |
| 2012-12-31 | $23.85 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 SurModics SRDX | $35.17 M | -82.04% | 🇺🇸 USA |
 Anika Therapeutics ANIK | $72.86 M | -62.79% | 🇺🇸 USA |
 Intersect ENT XENT | N/A | N/A | 🇺🇸 USA |
 Haemonetics HAE | $0.19 B | -0.93% | 🇺🇸 USA |